Pacific Biosciences of California PACB Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's accounts payable?
- Pacific Biosciences of California (PACB) reported accounts payable of $13.61M in Q1 2026.
- How has Pacific Biosciences of California's accounts payable changed year-over-year?
- Pacific Biosciences of California's accounts payable decreased by 3.0% year-over-year, from $14.04M to $13.61M.
- What is the long-term trend for Pacific Biosciences of California's accounts payable?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's accounts payable has grown at a 42.1% compound annual growth rate (CAGR), from $3.58M to $20.77M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.